Fundz

Real-time funding, M&A, exec moves & hiring — the signals that move deals

More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.

The funding market, moving in real timeBook a DemoChoose your plan
Loading live signals…

Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.

Back to SEC Filings
Executive ChangeItem 5.02 · 8-KLOW RiskPositive

Teladoc Health, Inc.

teladoc.com
Filed: Mar 30, 2026CIK: 0001477449Healthcare
Watch CompanyView on SEC.gov

AI Executive Summary

AI-powered analysis of 8-K filing content

Teladoc Health appointed Susan R. Salka as a new independent director and audit committee financial expert on March 30, 2026, expanding the board to nine members. This strengthens governance and financial oversight capabilities.

Key Takeaways

Board size increased from eight to nine directors with the appointment of Susan R. Salka

Ms. Salka designated as independent director under NYSE standards and audit committee financial expert per SEC regulations

2 more takeaways

Filing Overview

Form Type8-K
Filing DateMar 30, 2026
Item5.02
CategoryExecutive Change
CIK0001477449
Accession #tdoc-20260330
Risk LevelLOW
SentimentPositive
Signalinformational
Topics
board change

What This Means

A senior executive (CEO, CFO, etc.) has joined, departed, or changed roles. Leadership changes can significantly impact strategy.
View Full Filing on SEC.govBrowse More Filings